# Samsung Medical Center

Source: https://onco.cc/institutions/samsung-medical-center/  
OnCo record `samsung-medical-center` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Samsung Medical Center in Seoul is Korea's highest-ranked cancer hospital and one of Asia's largest enrolling sites for lung, gastric and breast antibody-drug conjugate trials; it also runs a proton therapy centre. How far its largely Korean trial results generalise to other regions is a question regulators keep asking.

## Summary

Samsung Medical Center in Seoul is Korea's highest-ranked cancer hospital, placed third in the Newsweek/Statista World's Best Specialized Hospitals list for oncology, and home to the Samsung Comprehensive Cancer Center. It matters to global drug development because it is a leading enroller in non-small-cell lung cancer, gastric cancer and breast antibody-drug conjugate trials, and it operates a proton therapy centre. OnCo links it to gastric and gastro-oesophageal junction cancer, to the DeLLphi-301 tarlatamab paper in small-cell lung cancer, to the Korean Cancer Study Group and to clinicians including Jeeyun Lee, Won Ki Kang and Woong-Yang Park. How far results from its largely Korean trial populations generalise to other regions is an open question that regulators keep asking. Its lung and gastric programmes are the ones to follow.

## Fields

- Kind: Institution
- Last checked: 2026-09-04
- City: Seoul, KR
- Type: hospital
- Website: https://www.samsunghospital.com

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/Samsung_Medical_Center
- Official website: https://www.samsunghospital.com
- PTCOG: particle therapy facilities in operation: https://www.ptcog.site/index.php/facilities-in-operation-public

## Connected records

- collections: [Newsweek/Statista World's Best Specialized Hospitals: Oncology](https://onco.cc/collections/newsweek-hospitals/)
- technologies: [Gamma Knife](https://onco.cc/technologies/gamma-knife/), [Proton therapy](https://onco.cc/technologies/proton-therapy/), [Proton therapy machines: cyclotrons, synchrotrons and single-room systems](https://onco.cc/technologies/proton-therapy-systems/), [Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS)](https://onco.cc/technologies/radiosurgery-srs/)
- people: [Ho Yeong Lim](https://onco.cc/people/lim-ho-yeong/), [Jeeyun Lee](https://onco.cc/people/lee-jeeyun/), [Jong-Mu Sun](https://onco.cc/people/jong-mu-sun/), [Keunchil Park](https://onco.cc/people/keunchil-park/), [Myung-Ju Ahn](https://onco.cc/people/ahn-myung-ju/), [Won Ki Kang](https://onco.cc/people/kang-won-ki/), [Woong-Yang Park](https://onco.cc/people/park-woong-yang/), [Yeon Hee Park](https://onco.cc/people/park-yeon-hee/)
- cancers: [Gastric & gastro-oesophageal junction cancer](https://onco.cc/cancers/gastric/)
- key papers: [DeLLphi-301: tarlatamab, a DLL3-targeting T-cell engager, in previously treated small-cell lung cancer](https://onco.cc/key-papers/paper-dellphi-301-nejm-2023/)
- companies: [Korean Cancer Study Group](https://onco.cc/companies/kcsg/), [Sumitomo Heavy Industries](https://onco.cc/companies/sumitomo-heavy-industries/)

---
JSON: https://onco.cc/api/v1/entities/samsung-medical-center.json